Imunon, Inc. (IMNN)
NASDAQ: IMNN · Real-Time Price · USD
0.9000
+0.0299 (3.44%)
At close: Nov 3, 2026, 4:00 PM EST
0.9130
+0.0130 (1.44%)
After-hours: Nov 3, 2026, 5:45 PM EST
Imunon Market Cap
Imunon has a market cap or net worth of $5.05 million as of November 3, 2026. It is the 44,782nd most valuable company in the world and the 5,962nd biggest in the United States. Its market cap has decreased by 49.50% in one year.
Market Cap
5.05M
Enterprise Value
6.03M
1-Year Change
-49.50%
Global Rank
Country Rank
#5,962 United States
Category
ChartMarket Cap Chart
Since March 1, 1999, Imunon's market cap has decreased from $37.70M to $5.05M, a decrease of -86.60%. That is a compound annual growth rate of -7.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2026 | 5.05M | -56.84% |
| Dec 31, 2025 | 11.70M | -15.22% |
| Dec 31, 2024 | 13.80M | 115.63% |
| Dec 29, 2023 | 6.40M | -36.00% |
| Dec 30, 2022 | 10.00M | -78.59% |
| Dec 31, 2021 | 46.70M | 75.56% |
| Dec 31, 2020 | 26.60M | -31.62% |
| Dec 31, 2019 | 38.90M | 47.35% |
| Dec 31, 2018 | 26.40M | -38.60% |
| Dec 29, 2017 | 43.00M | 444.30% |
| Dec 30, 2016 | 7.90M | -82.29% |
| Dec 31, 2015 | 44.60M | -4.09% |
| Dec 31, 2014 | 46.50M | -12.10% |
| Dec 31, 2013 | 52.90M | -81.56% |
| Dec 31, 2012 | 286.80M | 531.72% |
| Dec 30, 2011 | 45.40M | 73.95% |
| Dec 31, 2010 | 26.10M | -34.09% |
| Dec 31, 2009 | 39.60M | 77.58% |
| Dec 31, 2008 | 22.30M | -30.75% |
| Dec 31, 2007 | 32.20M | 57.07% |
| Dec 29, 2006 | 20.50M | -52.87% |
| Dec 30, 2005 | 43.50M | -52.51% |
| Dec 31, 2004 | 91.60M | -52.76% |
| Dec 31, 2003 | 193.90M | 367.23% |
| Dec 31, 2002 | 41.50M | -26.29% |
View and export this data all the way back to 1999. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Evogene | 5.48M |
| Longeveron | 5.45M |
| Can-Fite BioPharma | 5.31M |
| Pulmatrix | 5.11M |
| Azitra | 5.07M |
| Niki BioSolutions | 4.97M |
| Cardio Diagnostics Holdings | 4.94M |
| AIM ImmunoTech | 4.89M |